These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2237810)

  • 41. Systemic lytic state is not a predictor of coronary reperfusion in acute myocardial infarction.
    el Gaylani N; Davies S; Tovey J; Kinnarid T; Duly E; Buchalter MB
    Int J Cardiol; 1996 Nov; 57(1):45-50. PubMed ID: 8960942
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Platelet function after in vivo and in vitro treatment with thrombolytic agents.
    Bertolino G; Noris P; Previtali M; Gamba G; Ferrario M; Montani N; Balduini CL
    Am J Cardiol; 1992 Feb; 69(5):457-61. PubMed ID: 1736606
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Variable and circadian response to a fixed high-dose (12 500 IU twice daily) subcutaneous heparin regimen after thrombolytic therapy for acute myocardial infarction.
    Violaris AG; Trudgill NJ; Rowlands L; Gunn J; Tsikaderis D; Campbell S
    Coron Artery Dis; 1994 Mar; 5(3):257-65. PubMed ID: 8199741
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of coagulation and fibrinolysis after intravenous anisoylated plasminogen streptokinase activator complex or heparin in patients with acute myocardial infarction. A Belgian multicentre study.
    Renkin J; Beys CC; Lavenne-Pardonge E; Pintens H; Col J
    Drugs; 1987; 33 Suppl 3():253-60. PubMed ID: 3315603
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thrombolytic therapy in acute myocardial infarction: comparison of procoagulant effects of streptokinase and alteplase regimens with focus on the kallikrein system and plasmin.
    Hoffmeister HM; Szabo S; Kastner C; Beyer ME; Helber U; Kazmaier S; Wendel HP; Heller W; Seipel L
    Circulation; 1998 Dec; 98(23):2527-33. PubMed ID: 9843458
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Coagulation and fibrinolytic changes in evolving acute myocardial infarction treated by high-dose, brief-duration intracoronary or intravenous streptokinase.
    Lurie AA; Rogers WJ; Gross LF
    Am J Clin Pathol; 1990 Feb; 93(2):246-51. PubMed ID: 2301285
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.
    GUSTO investigators
    N Engl J Med; 1993 Sep; 329(10):673-82. PubMed ID: 8204123
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anisoylated plasminogen streptokinase activator complex (APSAC). A review of its mechanism of action, clinical pharmacology and therapeutic use in acute myocardial infarction.
    Monk JP; Heel RC
    Drugs; 1987 Jul; 34(1):25-49. PubMed ID: 3308411
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High dose intravenous streptokinase in acute myocardial infarction--short and long term prognosis.
    MacLennan BA; McMaster A; Webb SW; Khan MM; Adgey AA
    Br Heart J; 1986 Mar; 55(3):231-9. PubMed ID: 3954907
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Platelet function during and after thrombolytic therapy for acute myocardial infarction with reteplase, alteplase, or streptokinase.
    Moser M; Nordt T; Peter K; Ruef J; Kohler B; Schmittner M; Smalling R; Kübler W; Bode C
    Circulation; 1999 Nov; 100(18):1858-64. PubMed ID: 10545429
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma iron status and lipid peroxidation following thrombolytic therapy for acute myocardial infarction.
    Cottin Y; Doise JM; Maupoil V; Tannière-Zeller M; Dalloz F; Maynadié M; Walker MK; Louis P; Carli PM; Wolf JE; Rochette L
    Fundam Clin Pharmacol; 1998; 12(2):236-41. PubMed ID: 9565780
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fibrinolytic effects of intracoronary streptokinase administration in patients with acute myocardial infarction and coronary insufficiency.
    Cowley MJ; Hastillo A; Vetrovec GW; Fisher LM; Garrett R; Hess ML
    Circulation; 1983 May; 67(5):1031-8. PubMed ID: 6831667
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessment of fibrin degradation products during fibrinolytic therapy for acute myocardial infarction.
    Francis CW; Connaghan DG; Marder VJ
    Circulation; 1986 Nov; 74(5):1027-36. PubMed ID: 3533310
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Systemic short-term fibrinolysis with high-dose streptokinase in acute myocardial infarction: time course of biochemical parameters.
    Golf SW; Temme H; Kempf KD; Bleyl H; Brüstle A; Bödeker R; Heinrich D
    J Clin Chem Clin Biochem; 1984 Nov; 22(11):723-9. PubMed ID: 6396365
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Independent impact of thrombolytic therapy and vessel patency on left ventricular dilation after myocardial infarction. Serial echocardiographic follow-up.
    Popović AD; Nesković AN; Babić R; Obradović V; Bozinović L; Marinković J; Lee JC; Tan M; Thomas JD
    Circulation; 1994 Aug; 90(2):800-7. PubMed ID: 8044951
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association between admission mean platelet volume and coronary patency after thrombolytic therapy for acute myocardial infarction.
    Yaşar AS; Bilen E; Yüksel IO; Arslantaş U; Karakaş F; Kirbaş O; Bilge M
    Turk Kardiyol Dern Ars; 2010 Mar; 38(2):85-9. PubMed ID: 20473008
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reduced infarct size in nonreperfused myocardial infarction by combined infusion of isosorbide dinitrate and streptokinase.
    Hildebrandt P; Torp-Pedersen C; Joen T; Iversen E; Jensen G; Jeppesen D; Melchior T; Schytten HJ; Ringsdal V; Jensen J
    Am Heart J; 1992 Nov; 124(5):1139-44. PubMed ID: 1442478
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Usefulness of a rapid initial increase in plasma creatine kinase activity as a marker of reperfusion during thrombolytic therapy for acute myocardial infarction.
    Lewis BS; Ganz W; Laramee P; Cercek B; Hod H; Shah PK; Lew AS
    Am J Cardiol; 1988 Jul; 62(1):20-4. PubMed ID: 3381752
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of early thrombolytic therapy (anistreplase versus streptokinase) on enzymatic and electrocardiographic infarct size in acute myocardial infarction. TEAM-2 Investigators.
    Karagounis L; Moreno F; Menlove RL; Ipsen S; Anderson JL
    Am J Cardiol; 1991 Oct; 68(9):848-56. PubMed ID: 1927942
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transient release of lipid peroxidation products as a non-invasive marker of successful reperfusion after thrombolysis for myocardial infarction.
    Ohlin H; Gustavsson CG; Pantev E; Thorvinger B; Ohlin AK
    Br Heart J; 1995 Mar; 73(3):223-6. PubMed ID: 7727180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.